Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Common Equity (2020 - 2025)

iSpecimen (ISPC) has 6 years of Common Equity data on record, last reported at $3.1 million in Q3 2025.

  • For Q3 2025, Common Equity fell 34.83% year-over-year to $3.1 million; the TTM value through Sep 2025 reached $3.1 million, down 34.83%, while the annual FY2024 figure was $3.3 million, 66.01% down from the prior year.
  • Common Equity reached $3.1 million in Q3 2025 per ISPC's latest filing, up from $621973.0 in the prior quarter.
  • Across five years, Common Equity topped out at $29.8 million in Q4 2021 and bottomed at -$31.2 million in Q1 2021.
  • Average Common Equity over 5 years is $10.5 million, with a median of $10.7 million recorded in 2021.
  • Peak YoY movement for Common Equity: surged 209.21% in 2021, then crashed 89.79% in 2025.
  • A 5-year view of Common Equity shows it stood at $29.8 million in 2021, then plummeted by 31.83% to $20.3 million in 2022, then crashed by 52.04% to $9.7 million in 2023, then plummeted by 66.01% to $3.3 million in 2024, then decreased by 7.2% to $3.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Common Equity were $3.1 million in Q3 2025, $621973.0 in Q2 2025, and $1.7 million in Q1 2025.